Wedbush maintains Cinemark Holdings at Outperform, raises price target to $46 from $45

Wedbush reaffirmed its Outperform rating for Cinemark Holdings and increased its price target to $46 from $45, suggesting a 19.4% upside from the Nov 3 close of $38.51. Recent analyst targets for the company range from $41 to $45.

Original reporting
Published Nov 4, 2026, 2:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 2:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Wedbush maintains Cinemark Holdings at Outperform, raises price target to $46 from $45 — source image
Decision brief

The 30-second read

$CNKBullishMed
01

Why it matters

The incremental target raise signals a slightly more favorable outlook but is unlikely to trigger a sharp move.

02

Market read

A small analyst target increase with limited immediate trading impact.

03

What to watch

Potential headwinds from streaming competition and post‑pandemic attendance trends could limit upside.

Relevance 6/10Novelty 5/10Timing: today

Background

Wedbush maintains an Outperform rating on Cinemark Holdings and nudges its price target upward by $1.

Company-level read

Ticker impact

$CNKBullishMedium confidence
Context

Wedbush raised its price target on Cinemark Holdings to $46 from $45, indicating a modest upgrade.

Expected impact

likely modest upside as investors price in the higher target

Evidence & confidence

The target increase is small (2.2%) and reflects a modest improvement in outlook, which may attract incremental buying.

Market effects

Minor impact on the cinema/exhibition sector as analysts adjust expectations.

Limited to U.S. equities; no broader regional effect.

Low global relevance.

Counterpoint

The upgrade is modest and may already be priced in; investors could wait for stronger catalysts.

Key entities

  • Cinemark Holdings Inc.

    U.S. cinema operator whose stock ticker is CNK.

  • Wedbush Securities

    Equity research firm providing the rating and target update.

Related articles

$CNKHigh

Morgan Stanley upgrades Cinemark stock rating on box office outlook

Morgan Stanley upgraded Cinemark (CNK) to Overweight with a $50 price target, citing optimism about 2027 box office growth and the company's strong market position. Cinemark's stock has risen 75.3% year-to-date, trading near its 52-week high. The company reported record Q3 earnings of $1.04 per share on $1.06 billion revenue, exceeding expectations. Other analysts have also raised their price targets following the strong performance.

$CNKHighAI 8/10

StoneX raises Cinemark stock price target on strong quarter

StoneX raised its price target on Cinemark (NYSE:CNK) to $45 from $40, citing strong Q3 results with revenue and adjusted EBITDA exceeding estimates. The firm expects continued growth in 2027, supported by a strong film slate and premium expansion. Cinemark's stock has surged 42% in six months. The company reported record Q3 earnings of $1.04 per share, beating estimates, with revenue reaching $1.06 billion.

$CNKMedAI 8/10

Cinemark stock holds at Neutral as B.Riley keeps $42 target

B.Riley maintained a Neutral rating and $42 price target for Cinemark (CNK) after its Q3 earnings beat estimates. Revenue was $1.059B, EBITDA $268M, driven by Latin America sales. Management is optimistic about future box office growth. Shares are up 65% YTD, trading near a 52-week high. Wells Fargo raised its target to $42, citing international success.

$CNKMed

Cinemark Holdings Inc (CNK) (Q3 2026) Earnings Call Highlights: Record Q3 Revenue

Cinemark Holdings (CNK) reported record Q3 2026 revenue, but faced market share compression due to film mix and capacity constraints. The company expects similar challenges in Q4. Cinemark declined to book Netflix's 'Cliff Booth' on IMAX, citing concerns about the release model. Inflationary pressures and capacity constraints are impacting operations. The company has excess cash and may increase buybacks or dividends. CapEx could rise to invest in new builds and theater enhancements.